Abstract
Background and aims
Post-operative Crohn’s disease (CD) recurrence is common after intestinal resection. The European Crohn’s and Colitis Organization has issued guidelines regarding the optimal post-operative management of patients who have undergone intestinal resection for CD. The current study aims to assess the current adjuvant therapy practices of colorectal surgeons and gastroenterologists.
Methods
An electronic-based survey was sent to members of the Association of Coloproctology of Great Britain and Ireland and the Irish Society of Gastroenterology.
Results
One hundred twenty-five surgeons and gastroenterologists responded. Gastroenterologists more frequently assessed for pre-clinical recurrence with serum inflammatory markers (97 vs. 51 %, P < 0.001), faecal calprotectin (30 vs. 10 %, P = 0.008) and ileocolonoscopy (67 vs. 23 %, P < 0.001), while surgeons more frequently performed a CT scan (23 vs. 6 %, P = 0.037). The majority of respondents estimated the 1-year endoscopic recurrence to be 10–25 %, and 36 % of respondents offered prophylaxis to all post-operative patients. Budesonide (8 vs. 4 %, P = 0.006) and azathioprine/mercaptopurine (60 vs. 33 %, P < 0.001) were more often prescribed for high-risk patients, while imidazole antibiotics (11 vs. 5 %, P < 0.001) and 5-ASA derivatives were more often prescribed for low-risk patients (51 vs. 14 %, P < 0.001).
Conclusion
Currently, surgeons and gastroenterologists involved in the peri-operative care of patients with CD underestimate the risk of recurrence following intestinal resection and under-utilize ileocolonoscopy to tailor adjuvant therapy.
Similar content being viewed by others
References
Sachar DB (2006) Recurrence rates in Crohn’s disease: predicting the future and predicting the past. Gut 55:1069–1070
Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231:38–45
Olaison G, Smedh K, Sjodahl R (1992) Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 33:331–335
Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G (1984) Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut 25:665–672
Lock MR, Farmer RG, Fazio VW, Jagelman DG, Lavery IC, Weakley FL (1981) Recurrence and reoperation for Crohn’s disease: the role of disease location in prognosis. N Engl J Med 304:1586–1588
Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963
Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Jahnsen J, Moum B, Klump B, Krawczak M, Mirza MM, Foelsch UR, Vatn M, Schreiber S (2002) Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. Lancet 359:1661–1665
Cunningham MF, Docherty NG, Coffey JC, Burke JP, O’Connell PR (2010) Postsurgical recurrence of ileal Crohn’s disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg 34:1615–1626
Ahmed T, Rieder F, Fiocchi C, Achkar JP (2011) Pathogenesis of postoperative recurrence in Crohn’s disease. Gut 60:553–562
D’Haens GR, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G, Rutgeerts P (2008) Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology 135:1123–1129
Regueiro M et al (2009) Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 136(441):441–450, quiz 716
Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, Dotan I, Marteau P, Ardizzone A, Baumgart DC, D’Haens G, Gionchetti P, Portela F, Vucelic B, Soderholm J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G, Reinshagen M, Tsianos E, Herrlinger K, Oldenburg B, Bouhnik Y, Kiesslich R, Stange E, Travis S, Lindsay J (2010) The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohn’s Colitis 4:63–101
Renna S, Camma C, Modesto I, Cabibbo G, Scimeca D, Civitavecchia G, Mocciaro F, Orlando A, Enea M, Cottone M (2008) Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn’s disease. Gastroenterology 135:1500–1509
Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR (2008) Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Aliment Pharmacol Ther 28:545–556
Walters TD, Steinhart AH, Bernstein CN, Tremaine W, McKenzie M, Wolff BG, McLeod RS (2011) Validating Crohn’s disease activity indices for use in assessing postoperative recurrence. Inflamm Bowel Dis 17:1547–1556
Regueiro M, Kip KE, Schraut W, Baidoo L, Sepulveda AR, Pesci M, El-Hachem S, Harrison J, Binion D (2011) Crohn’s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis 17:118–126
Koilakou S, Sailer J, Peloschek P, Ferlitsch A, Vogelsang H, Miehsler W, Fletcher J, Turetschek K, Schima W, Reinisch W (2010) Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn’s disease after ileocolic resection. Inflamm Bowel Dis 16:198–203
Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W (2008) Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol 18:2512–2521
Bourreille A, Jarry M, D’Halluin PN, Ben-Soussan E, Maunoury V, Bulois P, Sacher-Huvelin S, Vahedy K, Lerebours E, Heresbach D, Bretagne JF, Colombel JF, Galmiche JP (2006) Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study. Gut 55:978–983
Pallotta N, Giovannone M, Pezzotti P, Gigliozzi A, Barberani F, Piacentino D, Hassan NA, Vincoli G, Tosoni M, Covotta A, Marcheggiano A, Di Camillo M, Corazziari E (2010) Ultrasonographic detection and assessment of the severity of Crohn’s disease recurrence after ileal resection. BMC Gastroenterol 10:69
Calabrese E, Petruzziello C, Onali S, Condino G, Zorzi F, Pallone F, Biancone L (2009) Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 15:1635–1642
Doherty GA, Bennett GC, Cheifetz AS, Moss AC (2010) Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn’s disease. Aliment Pharmacol Ther 31:802–809
Gordon M, Naidoo K, Thomas AG, Akobeng AK: Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn’s disease, Cochrane Database Syst Rev 2011, CD008414
Ford AC, Khan KJ, Talley NJ, Moayyedi P (2011) 5-aminosalicylates prevent relapse of Crohn’s disease after surgically induced remission: systematic review and meta-analysis. Am J Gastroenterol 106:413–420
Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC: Interventions for prevention of post-operative recurrence of Crohn’s disease, Cochrane Database Syst Rev 2009, CD006873
Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR (2010) Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn’s disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 59:752–759
French H, Mark Dalzell A, Srinivasan R, El-Matary W (2011) Relapse rate following azathioprine withdrawal in maintaining remission for Crohn’s disease: a meta-analysis. Dig Dis Sci 56:1929–1936
Regueiro M, El-Hachem S, Kip KE, Schraut W, Baidoo L, Watson A, Swoger J, Schwartz M, Barrie A, Pesci M, Binion D (2011) Postoperative infliximab is not associated with an increase in adverse events in Crohn’s disease. Dig Dis Sci 56:3610–3615
Yamamoto T, Umegae S, Matsumoto K (2009) Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn’s disease: a prospective pilot study. Inflamm Bowel Dis 15:1460–1466
Morris E, Haward RA, Gilthorpe MS, Craigs C, Forman D (2006) The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire’s colorectal cancer patients. Br J Cancer 95:979–985
Ricci C, Lanzarotto F, Lanzini A (2008) The multidisciplinary team for management of inflammatory bowel diseases, digestive and liver disease. Off J Ital Soc Gastroenterol Ital Assoc Study Liver 40(Suppl 2):S285–S288
Aufses AH Jr (2000) The history of surgery for Crohn’s disease at the Mount Sinai Hospital. Mt Sinai J Med N Y 67:198–203
Acknowledgments
The authors would like to thank Ms Anne O’Mara of the ACPGBI for providing access to the association mailing list and Mr Michael Dineen of the ISG for forwarding the Society members the presented survey.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burke, J.P., Doherty, G.A. & O’Connell, P.R. A survey of current practices used to maintain surgically induced remission following intestinal resection for Crohn’s disease. Int J Colorectal Dis 28, 1073–1079 (2013). https://doi.org/10.1007/s00384-013-1668-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-013-1668-y